Kirjojen hintavertailu – 12 903 725 kirjaa ja 27 kauppaa

Kirjailija

David Albala

Kirjat ja teokset yhdessä paikassa: 5 kirjaa, julkaisuja vuosilta 2018–2022, suosituimpiin kuuluu Management of Non-Muscle Invasive Bladder Cancer. Vertaile teosten hintoja ja tarkista saatavuus suomalaisista kirjakaupoista.

5 kirjaa

Kirjojen julkaisuvuodet: 2018–2022.

Management of Muscle Invasive Bladder Cancer

Management of Muscle Invasive Bladder Cancer

Sanchia S. Goonewardene; Karen Ventii; Amit Bahl; Raj Persad; Hanif Motiwala; David Albala

Springer Nature Switzerland AG
2022
nidottu
This book provides a systematic review of the management and treatment of this disease. The concise and highly structured chapters feature essential background knowledge and commentary on recent advances within each step of a range of patient pathways. Management of Muscle Invasive Bladder Cancer provides a framework for patients’ care based on the research, as well as practically and clinically oriented guidelines. This book is relevant to trainees and practicing urologists and oncologists, in addition to medical professionals involved in the treatment of bladder cancer.
Management of Muscle Invasive Bladder Cancer

Management of Muscle Invasive Bladder Cancer

Sanchia S. Goonewardene; Karen Ventii; Amit Bahl; Raj Persad; Hanif Motiwala; David Albala

Springer Nature Switzerland AG
2021
sidottu
This book provides a systematic review of the management and treatment of this disease. The concise and highly structured chapters feature essential background knowledge and commentary on recent advances within each step of a range of patient pathways. Management of Muscle Invasive Bladder Cancer provides a framework for patients’ care based on the research, as well as practically and clinically oriented guidelines. This book is relevant to trainees and practicing urologists and oncologists, in addition to medical professionals involved in the treatment of bladder cancer.
Management of Non-Muscle Invasive Bladder Cancer

Management of Non-Muscle Invasive Bladder Cancer

Sanchia S. Goonewardene; Raj Persad; Hanif Motiwala; David Albala

Springer Nature Switzerland AG
2020
nidottu
This book covers the latest advances in non-muscle invasive bladder cancer care. It provides a review of the available evidence base for the efficacy of a range of therapeutic techniques, diagnostic procedures and risk factors. Management of Non-Muscle Invasive Bladder Cancer features detailed guidance in uniformly formatted chapters on how to properly apply a range of available therapeutic treatments relevant for patient care. It is a valuable resource for all trainee and practising medical professionals who treat these patients.
Management of Non-Muscle Invasive Bladder Cancer

Management of Non-Muscle Invasive Bladder Cancer

Sanchia S. Goonewardene; Raj Persad; Hanif Motiwala; David Albala

Springer Nature Switzerland AG
2019
sidottu
This book covers the latest advances in non-muscle invasive bladder cancer care. It provides a review of the available evidence base for the efficacy of a range of therapeutic techniques, diagnostic procedures and risk factors. Management of Non-Muscle Invasive Bladder Cancer features detailed guidance in uniformly formatted chapters on how to properly apply a range of available therapeutic treatments relevant for patient care. It is a valuable resource for all trainee and practising medical professionals who treat these patients.
Basic Urological Management

Basic Urological Management

Sanchia S. Goonewardene; Peter Pietrzak; David Albala

Springer International Publishing AG
2018
sidottu
This book describes basic urological conditions and their management, with flowcharts to illustrate each step of patient treatment. Topics related to the upper and lower tract, urological infections, trauma, incontinence, andrology, and uro-oncology are all covered. The management of each condition is explained through point by point analysis that details patient pathways. Basic Urological Management aims to aid management decision making within urology and at specific points within patient pathways.